Literature Review

ILAE offers first guide to treating depression in epilepsy
Recommendations cover first-line treatment of unipolar depression in epilepsy without other psychiatric disorders.
Recommendations cover first-line treatment of unipolar depression in epilepsy without other psychiatric disorders.
Most of the genetic mutations were spontaneous and not inherited from the parents.
“This prospective observational study confirms the epidemiologic data that even after mild brain injury, there is an increased risk for epilepsy...
Epileptic seizures in older adults tend to be less dramatic with fewer motor manifestations.
“It’s still a good drug,” former AES chief says, but “we need to plan more carefully when we use it.”
Most tests were negative, but positive ones usually led to changes in medical management.
Altered status in patients should trigger consideration of EEGs, researcher says.
Findings suggest higher risk although researchers haven’t adjusted findings for confounders yet.
It’s not clear how the deterioration may affect day-to-day cognition.
Adolescents feel pressure to be the best at everything. “They wanted to be good in athletics; they wanted to be good in academics; they wanted to...
Women with epilepsy are also more likely to report other stressors, including divorce, illness, lost pay, and partner discord, while expecting.
Among patients with epilepsy, common comorbidities include anxiety and mood disorders, hypertension, back problems, developmental disorders,...
“Our findings further expand upon our knowledge of the negative effects hypertension has on brain health.”
Researchers studied evaluation and management before and after AAP’s 2011 simple febrile seizure guidelines and found that limiting diagnostic...
But neurologists caution colleagues to be careful with the intoxicating cannabis component.
The novelty of the new treatment approach is the duration of therapy as well as the dual antiglutamate drugs.
Positive findings from genetic testing helped guide clinical management in 50% of cases and improved patient outcomes in 75%.
“Children with epilepsy are at risk of being used as the ‘Trojan horse’ for the cannabis industry.”
The approval marks the first time that the IV formulation will be available for children.
“How many patients are afraid of their medication and do not take it because of the warning?”